National Gaucher Foundation - Gaucher Disease
Slideshow Image 1
Slideshow Image 2
Slideshow Image 3

Gaucher Disease News at a Glance

Apr 7, 2014 - Gaucher-Canada Boston Marathon Connection

Mar 31, 2014 - Patients with type 1 Gaucher disease in South Florida, USA: demographics, genotypes, disease severity and treatment outcomes

Mar 25, 2014 - Pfizer® Consolidates Patient Assistance Program into One Program Called Pfizer RxPathways™ on April 1, 2014

Mar 18, 2014 - Genzyme Presents Safety Overview For Cerdelga™

Mar 14, 2014 - Shire Pharmaceuticals Initiates Voluntary Nationwide Recall Of One batch, Packaged into Three Lots of VPRIV®

Mar 12, 2014 - Urgent laws for genotype tests needed

Mar 4, 2014 - CIRM’s YouTube stem cell channel tops half a million views

Feb 25, 2014 - Statement Relating To Shire’s Vpriv® (Velaglucerase Alfa For Injection) Press Release Dated June 28, 2012

Feb 14, 2014 - FDA Approves Shire's Manufacturing Facility For Vpriv Drug

Feb 13, 2014 - Protalix BioTherapeutics Announces Oral GCD Data to be Presented at WORLD Symposium 2014

Jan 23, 2014 - Protalix Announces Successful Manufacturing Facility Evaluation by Health Canada - taliglucerase alfa for Gaucher

Jan 23, 2014 - New hope for Gaucher patients

Jan 10, 2014 - EU panel recommends suspension of risky bone disease drug

Jan 09, 2014 - Lawyers assures HC of helping rickshawpuller's son's treatment

Jan 07, 2014 - POSITION STATEMENT NATIONAL GAUCHER FOUNDATION MEDICAL ADVISORY BOARD

Jan 07, 2014 - A Rare-Disease Champion For Gaucher Disease